Document is current
Any future updates will be listed below
-
Authors
Yeo, Muhan
Lee, So-Ryoung
Choi, Eue-Keun
Choi, JungMin
Lee, Kyung-Yeon
Kwon, Soonil
Ahn, Hyo-Jeong
Kim, Bong-Seong
Han, Kyung-Do
Oh, Seil
Lip, Gregory Y. H.
-
Funding
Funding for this research was provided by:
Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea (RS-2021-KH119931)
National Research Foundation of Korea (IRIS RS-2024-00340590)
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 9 January 2025
First Online: 24 January 2025
Declarations
:
: This study received an exemption from the IRB of Seoul National University Hospital (IRB no. 2408-098-1562). Informed consent was not obtained because the database was anonymized. The utilization of the NHID for 2009–2023 will be approved in 2024.
: Not applicable.
: EKC: Research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Samsung Electronics Co., Ltd., Seers Technology, and Skylabs. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator.
